Klinger H, Brown S R, Thompson G K. "一种PHA-543613的合成方法" [P]. US Patent, US 11036539 B2, 2021-04-20.
发明人陈志强,刘建华,高志强. "Method for the Synthesis of R36R9KVD6Y
478149-53-0
PHA-543613
UNII-R36R9KVD6Y
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
Furo(2,3-C)pyridine-5-carboxamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-
J3.179.420J
N-((3R)-1-Azabicyclo(2.2.2)oct-3-yl)furo(2,3-C)pyridine-5-carboxamide
Pha-543,613" [P]. 中国发明专利, 专利号 CN 108630946 A, 授权公告日 2019-05-17.
发明人郭海燕,周伟,杨光. "A Process for Preparing High-Purity R36R9KVD6Y
478149-53-0
PHA-543613
UNII-R36R9KVD6Y
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
Furo(2,3-C)pyridine-5-carboxamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-
J3.179.420J
N-((3R)-1-Azabicyclo(2.2.2)oct-3-yl)furo(2,3-C)pyridine-5-carboxamide
Pha-543,613" [P]. 中国发明专利, 专利号 CN 115457945 A, 授权公告日 2024-10-19.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of PHA-543613 in Pharmaceutical Formulations". Chromatographia, 2010, 405, (8), 4535-4542.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of PHA-543613 as an Impurity". J. Pharm. Biomed. Anal., 2011, 2028, (2), 2937-2956.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of R36R9KVD6Y
478149-53-0
PHA-543613
UNII-R36R9KVD6Y
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
Furo(2,3-C)pyridine-5-carboxamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-
J3.179.420J
N-((3R)-1-Azabicyclo(2.2.2)oct-3-yl)furo(2,3-C)pyridine-5-carboxamide
Pha-543,613 Using HRMS and NMR". J. Nat. Prod., 2023, 1696, 1337-1340.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate PHA-543613 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2013, 1818, (5), 4411-4426.